X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (62) 62
female (37) 37
male (36) 36
middle aged (34) 34
hematology (33) 33
adult (29) 29
oncology (24) 24
aged (22) 22
immunotherapy (17) 17
index medicus (16) 16
treatment outcome (16) 16
antineoplastic combined chemotherapy protocols - therapeutic use (15) 15
dendritic cells (14) 14
lymphoma (14) 14
vaccination (13) 13
cancer vaccines - immunology (11) 11
chemotherapy (11) 11
follicular lymphoma (11) 11
immunoglobulin idiotypes - immunology (11) 11
lymphomas (11) 11
non-hodgkins-lymphoma (11) 11
survival analysis (11) 11
vaccines (11) 11
animals (10) 10
classification (10) 10
combined modality therapy (10) 10
therapy (10) 10
adolescent (9) 9
cancer (9) 9
colony-stimulating factor (9) 9
disease-free survival (9) 9
mice (9) 9
remission induction (9) 9
cancer vaccines (8) 8
cancer vaccines - therapeutic use (8) 8
follow-up studies (8) 8
high-dose chemotherapy (8) 8
lymphoma, follicular - immunology (8) 8
prognosis (8) 8
survival rate (8) 8
tumors (8) 8
clinical trials (7) 7
dendritic cells - immunology (7) 7
disease (7) 7
health aspects (7) 7
immune response (7) 7
prednisone - administration & dosage (7) 7
vincristine - administration & dosage (7) 7
aged, 80 and over (6) 6
b-cell lymphoma (6) 6
bleomycin - administration & dosage (6) 6
care and treatment (6) 6
cyclophosphamide - administration & dosage (6) 6
idiotype (6) 6
idiotype vaccine (6) 6
immunoglobulin idiotypes - therapeutic use (6) 6
lymphoma, non-hodgkin - drug therapy (6) 6
medicine, research & experimental (6) 6
radiotherapy (6) 6
research (6) 6
antineoplastic agents - therapeutic use (5) 5
antitumor immunity (5) 5
aptamer (5) 5
base sequence (5) 5
combination chemotherapy (5) 5
fludarabine (5) 5
hodgkin's disease (5) 5
hybridoma (5) 5
immunology (5) 5
lymphoma, follicular - therapy (5) 5
n-glycosylation sites (5) 5
recurrence (5) 5
retrospective studies (5) 5
survival (5) 5
trial (5) 5
antibodies (4) 4
antigens (4) 4
b-cell malignancies (4) 4
bone-marrow transplantation (4) 4
cell biology (4) 4
cytarabine - administration & dosage (4) 4
doxorubicin - administration & dosage (4) 4
expression (4) 4
feasibility studies (4) 4
hodgkin disease - drug therapy (4) 4
immune-responses (4) 4
international prognostic index (4) 4
large-cell lymphoma (4) 4
leucovorin - administration & dosage (4) 4
lymphocyte activation (4) 4
lymphocytes (4) 4
lymphoma - immunology (4) 4
lymphoma, non-hodgkin - pathology (4) 4
medicine (4) 4
methotrexate - administration & dosage (4) 4
molecular sequence data (4) 4
neoplasm staging (4) 4
neoplasms - immunology (4) 4
vaccine (4) 4
vidarabine - analogs & derivatives (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Nature Reviews Cancer, ISSN 1474-175X, 09/2009, Volume 9, Issue 9, pp. 675 - 681
Journal Article
CA: A Cancer Journal for Clinicians, ISSN 0007-9235, 09/2008, Volume 58, Issue 5, pp. 305 - 317
Journal Article
Journal of Translational Medicine, ISSN 1479-5876, 05/2017, Volume 15, Issue 1, pp. 104 - 12
Background: Prognosis of patients with glioblastoma multiforme (GBM) remains dismal, with median overall survival (OS) of about 15 months. It is therefore... 
Dendritic cell | Overall survival | Immunotherapy | Glioblastoma | SURVIVAL | MEDICINE, RESEARCH & EXPERIMENTAL | VOLUMETRIC-ANALYSIS | RESECTION | MULTIFORME | ADJUVANT TEMOZOLOMIDE | MALIGNANT GLIOMA | EXTENT | 5-AMINOLEVULINIC ACID | CENTRAL-NERVOUS-SYSTEM | RADIOTHERAPY | Inflammation - pathology | Chemoradiotherapy - adverse effects | Dendritic Cells - immunology | Humans | Middle Aged | Fluorescence | Male | Transplantation, Autologous | Vaccination - adverse effects | Brain Neoplasms - surgery | Feasibility Studies | Brain Neoplasms - immunology | Brain Neoplasms - blood | Adult | Female | Cytokines - blood | Glioblastoma - blood | Combined Modality Therapy | Glioblastoma - surgery | Glioblastoma - therapy | Disease-Free Survival | Glioblastoma - immunology | Brain Neoplasms - therapy | Survival Analysis | Aged | Care and treatment | Usage | Chemotherapy | Dendritic cells | Vaccination | Clinical trials | Research | Diagnosis | Health aspects | Glioblastoma multiforme | Fluorescence microscopy | Cancer | Volumetric analysis | Correlation | Prognosis | Nuclear magnetic resonance--NMR | Neurosurgery | Vaccines | Multivariate analysis | Cancer therapies | Blood | O6-methylguanine-DNA methyltransferase | Hepatitis | Surgery | Peripheral blood | Age | Failure | Deoxyribonucleic acid--DNA | Immune system | Immune response | Cell survival | Feasibility studies | Radio | Radiation therapy | Patients | Survival | Screening | Side effects | Monocytes | Searching | Medical prognosis | DNA methyltransferase | Temozolomide | Tumors
Journal Article
PLoS ONE, ISSN 1932-6203, 09/2017, Volume 12, Issue 9, p. e0185169
Journal Article
Reviews on recent clinical trials, ISSN 1574-8871, 2006, Volume 1, Issue 1, pp. 67 - 74
The most accepted and least biased manner to demonstrate clinical benefit for any new treatment is to show that it conveys a survival advantage in a... 
Vaccines - immunology | Clinical Trials as Topic | Vaccines - therapeutic use | Immunoglobulin Idiotypes | Humans | Immunotherapy
Journal Article
SCIENTIFIC REPORTS, ISSN 2045-2322, 10/2019, Volume 9, Issue 1, pp. 1 - 7
We sought to identify candidate biomarkers for early brain metastasis (BM) recurrence in patients who underwent craniotomy followed by adjuvant stereotactic... 
SALVAGE | SURVIVAL | IMMUNE-SYSTEM | QUALITY | MULTIDISCIPLINARY SCIENCES | COLORECTAL-CANCER CELLS | RADIOTHERAPY | OUTCOMES | FAILURE | NOMOGRAM | RADIATION-THERAPY | Immunohistochemistry | Plasma | Statistical analysis | Lymphocytes B | Plasma cells | Lymphocytes T | Metastasis | Ribonucleic acid--RNA | Stains | Metastases
Journal Article
Journal of Investigative Dermatology, ISSN 0022-202X, 07/2007, Volume 127, Issue 7, pp. 1673 - 1680
Melanoma lesions can be frozen resulting in necrotic death of malignant cells and in tumor antigen release suitable for cross-presentation by professional... 
BREAST-CANCER | PULSED DENDRITIC CELLS | RESPONSE MODIFIER | TOLL-LIKE RECEPTORS | TOPICAL IMIQUIMOD | MALIGNANT-MELANOMA | ANTITUMOR IMMUNITY | SKIN METASTASES | IN-SITU | LANGERHANS CELLS | DERMATOLOGY | Adjuvants, Immunologic - administration & dosage | Adjuvants, Immunologic - pharmacology | Aminoquinolines - administration & dosage | Interferon-gamma - metabolism | Cryosurgery - methods | Melanoma, Experimental - surgery | Immunity - drug effects | Melanoma, Experimental - immunology | Antigens, Neoplasm - metabolism | Female | Aminoquinolines - pharmacology | Skin Neoplasms - surgery | Toll-Like Receptor 7 - agonists | Skin Neoplasms - immunology | Antigens, Neoplasm - immunology | Mice, Inbred C57BL | Membrane Glycoproteins - agonists | Vitiligo - etiology | Combined Modality Therapy | Animals | Mice | Cryosurgery - adverse effects | Interferon Inducers - administration & dosage | Administration, Topical | Interferon Inducers - pharmacology | Cream | Lymphocytes T | Grafting | Immunity | Cancer vaccines | Lethal dose | Vitiligo | Autografts | Ovalbumin | Immunological memory | Immune response | Cryosurgery | Dermatology | Tumor cells | Melanoma | Adjuvants | Data processing | Inflammation | Epitopes | Nodules | Antigen-presenting cells | Antigen (tumor-associated) | imiquimod | gamma -Interferon | Internet | Tumors
Journal Article
Journal Article
Molecular Therapy - Nucleic Acids, ISSN 2162-2531, 2013, Volume 2, Issue 6, p. e98
CD28 is one of the main costimulatory receptors responsible for the proper activation of T lymphocytes. We have isolated two aptamers that bind to the CD28... 
costimulation | aptamer | immunotherapy | Costimulation | Immunotherapy | Aptamer | SUPERAGONISTS | ANTIBODIES | MEDICINE, RESEARCH & EXPERIMENTAL | OLIGONUCLEOTIDE APTAMERS | RNA | IDIOTYPE VACCINES | RECEPTOR | INDUCTION | TUMOR-IMMUNITY | T-CELL RESPONSES | Original
Journal Article
Journal Article
BioMed Research International, ISSN 2314-6133, 2015, Volume 2015, pp. 648143 - 15
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2005, Volume 23, Issue 5, pp. 999 - 1010
Purpose To evaluate the feasibility and safety of intratumoral injection of autologous dendritic cells (DCs) transfected wi